China's bio-pharmaceutical market now ranks as the world's second largest, with licensing deals for so-called "innovative drugs" surpassing $60 billion in the first half of 2025. The growth reflects the global influence of Chinese-developed drugs. CGTN's Zheng Songwu visited pharmaceutical companies in Shanghai to understand how the sector is gaining international traction.